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Abstract
The present study explored whether the use of group medication with antibiotics in a Danish pig
herd was reduced after vaccination of the pigs against proliferative enteropathy (PE) caused by
Lawsonia intracellularis. 7900 pigs originating from a single commercial sow herd were vaccinated
against L. intracellularis, whereas 7756 pigs were kept as non-vaccinated controls. The pigs were
included batch-wise in the study with every second batch being vaccinated. In the vaccinated
batches, the consumption of oxytetracykline to treat PE was reduced by 79%, with a significantly
lower number of pigs being treated (P < 0.0001). Vaccination also resulted in a highly significant
improvement of average daily weight gain (+ 46 g/day; P = 9.55 × 10-31) and carcase weight (+ 1.25
kg; P = 4.54 × 10-05) as well as a shortened fattening period (-8 days; P = 2.01 × 10-45).
Findings
In pig producing countries,Lawsonia intracellularis is a
common intestinal infection with severe economic conse-
quences due to decreased growth rates and feed conver-
sion. In many herds, continuous therapy with antibiotics
is required to control the consequences of the infection
[1]. Therefore, L. intracellularis lead to increased use of
antibiotics. In Denmark, 93% of the pig herds are infected
with  L. intracellularis [2]. Danish farmers use a low
amount of antibiotics compared to farmers in many other
pig producing countries [3], but Danish farmers experi-
ence continuous pressure from the public to reduce the
amount of antibiotics further. Most of the antibiotics for
Danish pigs are used for weaners, and the most frequently
used compounds are tetracykline and macrolides [4],
both useful for treatment of PE. Hence, a significant
reduction of the use of antibiotics in the Danish pig pro-
duction might be achieved by an alternative approach to
PE.
An obvious alternative to antibiotics is vaccination. Vacci-
nation against L. intracellularis has proven effective in con-
trolling PE and improving production parameters in
infected herds [5]. Vaccination has also resulted in a sig-
nificant reduction in the amount of antibiotics used [6] or
has completely replaced the antibiotics [7]. However,
these studies were carried out in populations treated with
antibiotics at a higher level than generally done in Den-
mark. The question is whether vaccination against PE can
reduce the already low amount of antibiotics used for
Danish pigs further. The present study evaluates the effect
of vaccination against PE on the use of antibiotics and
selected production parameters in a herd with limited use
of antibiotics.
The study was carried out in a 650-sow specific pathogen
free (SPF) herd with a level of Salmonella infection below
the detection level. The herd produced one batch of
approximately 1000 pigs every 3rd week. At 31 days of
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age, the pigs were weaned and distributed between 2 nurs-
ery sites, and at 30 kg live weight, half of the pigs in a
batch were moved to two fattening sites on the same farm,
whereas the other half was sold to another farmer for fat-
tening. Before the study started, the farmer signed an
informed content sheet describing the trial. The experi-
ment was approved by the Danish Medicines Agency
(Journal No. 2615-114). The herd used no prophylactic
medications. Group medication of pigs was necessary to
treat weaning diarrhoea 1–2 weeks after weaning in half
of the batches, and a second treatment for diarrhoea was
used for approximately every third batch to treat diar-
rhoea in older pigs. This second round of diarrhoea was
caused by L. intracellularis. Infection with L. intracellularis
was confirmed by laboratory examination of diseased
intestines, and no other intestinal pathogens could be iso-
lated from these intestines. A serological analysis by ELISA
[8] was executed 5 weeks after the proposed age for vacci-
nation to confirm the correctness of timing of vaccination.
The presence of L. intracellularis was surveyed throughout
the study by analyses of L. intracellularis antibodies in
blood by ELISA.
The study was performed in a modified version of a paral-
lel group design with consecutive, batchwise inclusion of
pigs. The study included 16 batches of pigs and every sec-
ond batch was vaccinated with a live oral L. intracellularis
vaccine (Enterisol® Ileitis Vet., Boehringer-Ingelheim AS,
Copenhagen, Denmark), whereas remaining batches were
kept as non-vaccinated controls (Figure 1). The vaccine
was administered at 31 days of age in drinking water.
Before weaning, all pigs were ear tagged with an earmark
representing the batch number. On the batch level, date of
entrance and date of exit were recorded by the farmer. The
pigs were tattooed with a specific delivery number corre-
sponding to the earmark representing the batch before
they were shipped for slaughter. For each pig, the delivery
Study design Figure 1
Study design. Principle of inclusion of pigs in a study based on a modified parallel group design from a herd, which weaned 
1000 pigs every 3rd week. The study compares pigs vaccinated against proliferative enteropathy (PE) caused by Lawsonia intrac-
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number, date of slaughter and carcase weight was col-
lected from the slaughterhouse database.
During the trial, group medications with antibiotics were
recorded. The farmer treated diarrhoea following the
usual guidelines from the local veterinarian. These guide-
lines included criteria for initiating a treatment, i.e. clini-
cal signs. Diarrhoea occurring 1–3 weeks after weaning
was treated as weaning diarrhoea, whereas diarrhoea
occurring later was treated as PE. The use of antibiotics
was compared for each pharmacologic group of antibiot-
ics. The parameters were: Batch treated yes/no and Pig
treated yes/no, and results were simple counts of yes and
no's. A chi-square test was carried out to compare the vac-
cinated and the non-vaccinated batches and pigs. The
level of significance was P = 0.05. For both vaccinated and
non-vaccinated batches, the amount of antibiotics used
(gram or ml) was registered for each compound.
Production performance was compared at the individual
pig level for the parameters: days from weaning to slaugh-
ter, carcase weight and average daily weight gain (ADWG).
The carcase weight was obtained directly from the slaugh-
terhouse database, whereas the days from weaning to
slaughter and the ADWG for each pig was calculated from
the day of weaning represented by the batch number, the
date of delivery, the mean weight at weaning and the car-
case weight. The data set was checked for normality with
Shapiro-Wilk test and Kolmogorov-Smirnov test and sta-
tistical comparison of vaccinated pigs and non-vaccinated
controls was done with Student T-tests using a signifi-
cance level of P = 0.01.
In the nurseries, three products were used for group med-
ication during the study: Oxytetracykline (Premedox, Vir-
bac, Kolding, Denmark) for treatment of PE, and
aminoglycoside (Apralan, Elanco Animal Health, Lyngby,
Denmark) or sulpha/TMP (Trimazin, Scanvet, Fredens-
borg, Denmark) for treatment of post weaning diarrhoea
caused by Eschericia coli.
Treatment for PE was administered to 4 batches: one vac-
cinated batch and 3 non-vaccinated batches. In the medi-
cated vaccinated batch, only some of the pigs (pens) were
treated, whereas the treatment in the 3 non-vaccinated
batches was given to around 2900 out of the 3000 pigs. A
statistically significant difference was observed for the
number of treated pigs, both when each nursery site was
analysed separately and when nursery data was merged
(Table 1). The mean amount of oxytetracykline used per
batch was 1041 g for the vaccinated batches and 4860 g
for the non-vaccinated batches. In total, vaccination
reduced the amount of oxytetracykline used for the 8 vac-
cinated batches by more than 30 kg.
Ten batches of pigs received treatment for post weaning
diarrhoea (5 vaccinated and 5 non-vaccinated batches).
Significantly fewer vaccinated pigs (N = 3274) than non-
vaccinated controls (N = 3734) were treated for post
weaning diarrhoea (P < 0.0001). The 5 vaccinated batches
received sulpha/TMP treatment, but the local veterinarian
instructed the farmer to use aminoglycoside treatment for
the non-vaccinated batches because the diarrhoea in these
pigs theoretically could be caused by L. intracellularis.
Therefore, 4 out of the 5 non-vaccinated batches were
Table 1: Use of oxytetracykline in 8 batches of pigs vaccinated against proliferative enteropathy (PE) caused by Lawsonia intracellularis 
compared to 8 non-vaccinated batches.
Vaccinated Non-vaccinated Reduction after vaccination P-valuea
Total # pigs 7900 7756 - -
# batches 8 8 - -
# batches treated against PE 1 3 2 0.2482
# pigs treated against PE
Nursery site 1
300 2346 2046 < 0.0001
# pigs treated against PE
Nursery site 2
220 499 279 < 0.0001
Total # pigs treated against PE 520 2845 2325 < 0.0001
Vaccinated Non-vaccinated Reduction after vaccination Reduction in %
Total amount of oxytetracykline 8.3 kg 38.9 kg 30.5 kg 79
a: Chi-square testActa Veterinaria Scandinavica 2009, 51:1 http://www.actavetscand.com/content/51/1/1
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treated with sulpha/TMP. The use of different products
made a comparison between the total amount of antibi-
otic used for vaccinated and non-vaccinated batches
impossible.
In the fattening units, only one batch of pigs (vaccinated)
received group medication. This batch was treated with
Tilmicosin (Pulmotil, Elanco Animal Health, Lyngby,
Denmark) because the pigs suffered from a lower respira-
tory tract infection.
Slaughterhouse data were available from 3471 pigs (2083
vaccinated and 1388 non-vaccinated). These pigs origi-
nated from the last 10 batches. 2347 pigs (1524 vacci-
nated and 823 non-vaccinated) were fattened at one of the
fattening sites associated with the sow herd, whereas 1124
pigs (559 vaccinated and 565 non-vaccinated) were sold
before fattening. Vaccination improved the ADWG from
weaning to slaughter by 46 g/day (P = 9.55 × 10-31), short-
ened the period from weaning to slaughter by 8 days (P =
2.01 × 10-45) and increased the carcase weight by 1.25 kg
(P = 4.54 × 10-05).
The study focused on oral (group) medication rather than
parenteral treatment as oral medication was believed to
contribute the most to the overall consumption of antibi-
otics. Vaccination significantly reduced the number of
pigs treated with oxytetracykline, but a significant reduc-
tion was not detected for the number of batches treated. A
data set like the present with a high number of un-treated
batches gives rise to a high number of ties in a non-para-
metric statistical analysis. Therefore, it was actually the
low baseline level of consumption of antibiotics that pre-
vented significant differences to be obtained even though
the total consumption was reduced by as much as 79%.
The antibiotics for treatment of post weaning diarrhoea
were used equally for vaccinated and non-vaccinated
batches of pigs, but at the individual level, a significant
reduction in the number of treated pigs was observed after
vaccination. The live oral vaccine for prevention of PE
might have a stabilizing effect on the gut flora thereby also
reducing the need for treatment against post weaning
diarrhoea.
The reduced use of antibiotics in the nursery did not affect
the production parameters negatively. On the contrary,
the vaccinated pigs showed highly significant improve-
ments. Vaccination against L. intracellularis probably pro-
tects the pigs even before onset of disease, thus preventing
damage to the intestinal mucosa. The improved growth
rate of the vaccinated pigs might indicate an advantage of
prophylaxis compared to treatment, i.e. due to prevention
of chronic lesions or depressed growth during episodes of
diarrhoea
Abbreviations
ADWG: Average daily weight gain; SPF: Specific pathogen
free; This term refers to absence of infection with Myco-
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sidered free of a number of infectious diseases according
to the national disease status [9].
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